Fonte: aqui.Genetech is expecting to see results from a colon cancer study involving Avastin by April, according to media reports Tuesday. Avastin has already been approved for breast cancer, Lung cancer and colon cancer which has already speared. Genentech’s goal of the current study — which involves more than The 2,710-patients — is to show whether Avastin improves survival of patients after colon cancer surgery.
